Cargando…

Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis

BACKGROUND: Cell surface heparan sulfate proteoglycans (HSPGs) act as co-receptors for multiple families of growth factors that regulate animal cell proliferation, differentiation and patterning. Elimination of heparan sulfate during brain development is known to produce severe structural abnormalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jen, Yi-Huei Linda, Musacchio, Michele, Lander, Arthur D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746204/
https://www.ncbi.nlm.nih.gov/pubmed/19732411
http://dx.doi.org/10.1186/1749-8104-4-33
_version_ 1782172021989310464
author Jen, Yi-Huei Linda
Musacchio, Michele
Lander, Arthur D
author_facet Jen, Yi-Huei Linda
Musacchio, Michele
Lander, Arthur D
author_sort Jen, Yi-Huei Linda
collection PubMed
description BACKGROUND: Cell surface heparan sulfate proteoglycans (HSPGs) act as co-receptors for multiple families of growth factors that regulate animal cell proliferation, differentiation and patterning. Elimination of heparan sulfate during brain development is known to produce severe structural abnormalities. Here we investigate the developmental role played by one particular HSPG, glypican-1 (Gpc1), which is especially abundant on neuronal cell membranes, and is the major HSPG of the adult rodent brain. RESULTS: Mice with a null mutation in Gpc1 were generated and found to be viable and fertile. The major phenotype associated with Gpc1 loss is a highly significant reduction in brain size, with only subtle effects on brain patterning (confined to the anterior cerebellum). The brain size difference emerges very early during neurogenesis (between embryonic days 8.5 and 9.5), and remains roughly constant throughout development and adulthood. By examining markers of different signaling pathways, and the differentiation behaviors of cells in the early embryonic brain, we infer that Gpc1(-/- )phenotypes most likely result from a transient reduction in fibroblast growth factor (FGF) signaling. Through the analysis of compound mutants, we provide strong evidence that Fgf17 is the FGF family member through which Gpc1 controls brain size. CONCLUSION: These data add to a growing literature that implicates the glypican family of HSPGs in organ size control. They also argue that, among heparan sulfate-dependent signaling molecules, FGFs are disproportionately sensitive to loss of HSPGs. Finally, because heterozygous Gpc1 mutant mice were found to have brain sizes half-way between homozygous and wild type, the data imply that endogenous HSPG levels quantitatively control growth factor signaling, a finding that is both novel and relevant to the general question of how the activities of co-receptors are exploited during development.
format Text
id pubmed-2746204
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27462042009-09-18 Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis Jen, Yi-Huei Linda Musacchio, Michele Lander, Arthur D Neural Dev Research Article BACKGROUND: Cell surface heparan sulfate proteoglycans (HSPGs) act as co-receptors for multiple families of growth factors that regulate animal cell proliferation, differentiation and patterning. Elimination of heparan sulfate during brain development is known to produce severe structural abnormalities. Here we investigate the developmental role played by one particular HSPG, glypican-1 (Gpc1), which is especially abundant on neuronal cell membranes, and is the major HSPG of the adult rodent brain. RESULTS: Mice with a null mutation in Gpc1 were generated and found to be viable and fertile. The major phenotype associated with Gpc1 loss is a highly significant reduction in brain size, with only subtle effects on brain patterning (confined to the anterior cerebellum). The brain size difference emerges very early during neurogenesis (between embryonic days 8.5 and 9.5), and remains roughly constant throughout development and adulthood. By examining markers of different signaling pathways, and the differentiation behaviors of cells in the early embryonic brain, we infer that Gpc1(-/- )phenotypes most likely result from a transient reduction in fibroblast growth factor (FGF) signaling. Through the analysis of compound mutants, we provide strong evidence that Fgf17 is the FGF family member through which Gpc1 controls brain size. CONCLUSION: These data add to a growing literature that implicates the glypican family of HSPGs in organ size control. They also argue that, among heparan sulfate-dependent signaling molecules, FGFs are disproportionately sensitive to loss of HSPGs. Finally, because heterozygous Gpc1 mutant mice were found to have brain sizes half-way between homozygous and wild type, the data imply that endogenous HSPG levels quantitatively control growth factor signaling, a finding that is both novel and relevant to the general question of how the activities of co-receptors are exploited during development. BioMed Central 2009-09-04 /pmc/articles/PMC2746204/ /pubmed/19732411 http://dx.doi.org/10.1186/1749-8104-4-33 Text en Copyright © 2009 Jen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jen, Yi-Huei Linda
Musacchio, Michele
Lander, Arthur D
Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
title Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
title_full Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
title_fullStr Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
title_full_unstemmed Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
title_short Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
title_sort glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746204/
https://www.ncbi.nlm.nih.gov/pubmed/19732411
http://dx.doi.org/10.1186/1749-8104-4-33
work_keys_str_mv AT jenyihueilinda glypican1controlsbrainsizethroughregulationoffibroblastgrowthfactorsignalinginearlyneurogenesis
AT musacchiomichele glypican1controlsbrainsizethroughregulationoffibroblastgrowthfactorsignalinginearlyneurogenesis
AT landerarthurd glypican1controlsbrainsizethroughregulationoffibroblastgrowthfactorsignalinginearlyneurogenesis